Bioethics News

Team Makes Zika Drug Breakthrough

August 30, 2016

(Managed Care Magazine) – A team of researchers at Florida State University, Johns Hopkins University, and the National Institutes of Health has identified two groups of compounds that could potentially be used to treat Zika virus infection (ZVI)—one that stops the virus from replicating and the other that stops the virus from killing neuroprogenitor cells in the fetal brain. One of the drugs is already on the market as a treatment for tapeworm.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.